More than half of popular probiotics contain traces of gluten, according to an analysis performed by investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC). Tests on 22 top-selling probiotics revealed that 12 of them (or 55%) had detectable gluten.
More than half of all cancer patients experience pain, most often associated with the malignancy type, body location and disease progression. Pain researchers participating in a symposium at the American Pain Society Annual Scientific Meeting, www.americanpainsociety.org, today reported that the relationship between tumors and nerves drives persistent and breakthrough pain and tumor progression in certain types of cancers.
A head-to-head comparison of two biologic therapies used to treat a subset of patients with advanced kidney cancers provides much-needed clarity on the preferred treatment for the first line of attack.
People suffering chronic pain have valuable information to share about their condition and overall health that can help pain researchers and physicians in treatment planning, according to the head of the Patient Centered Outcomes Institute (PCORI) speaking at the American Pain Society annual scientific meeting.
The 12th World Congress of the International Neuromodulation Society scientific program, from June 8 - 11, 2015 in Montreal, will present landmark studies about neurostimulation therapy and investigations of potential breakthroughs.
Rutgers Cancer Institute of New Jersey investigators along with other colleagues have demonstrated that the immunotherapy drug pembrolizumab is generally well tolerated in those with small cell lung cancer, one of the most difficult to treat forms of lung cancer when it is in advanced stages. The results will be presented at the upcoming American Association of Clinical Oncology Annual Meeting.
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease –hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.
As the practice of genetically profiling patient tumors for clinical treatment decision making becomes more commonplace, a recent study from The University of Texas MD Anderson Cancer Center suggests that profiling normal DNA also provides an important opportunity to identify inherited mutations that could be critical for patients and their families.
"Innovations in Neuromodulation," a preconference of the International Neuromodulation Society 12th World Congress, presents updates and opinions from representatives of early–stage companies and venture capitalists to approximately 200 investors, entrepreneurs, device company executives, and medical professionals.
Ten-year survival of a rare malignancy called mesenchymal chondrosarcoma has been reported to be as low as 20 percent. But a Loyola study has found survival is not as dismal as prior reports. More than half (51 percent) of patients survived at least five years, and 43 percent survived at least 10 years.
On May 7, researchers are reporting a case study in which viable Ebola virus was present in the eye’s aqueous humor — the clear fluid in the front of the eye, between the lens and the cornea — 10 weeks after the virus was no longer detectable in the patient’s blood.
Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the Louise Eisenhardt Traveling Scholarship Award, Teresa Purzner, MD, presented her research, Quantitative Phosphoproteomics for Targeted Cancer Therapy.
Winner of the Leksell Radiosurgery Award, Deborah C. Marshall, recently presented her research, Survival Patterns of Patients with Cerebral Metastases after Multiple Rounds of Stereotactic Radiosurgery (SRS).
Winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, Karam Moon, MD, will be presenting his research, The Myth of Restenosis after Carotid Angioplasty and Stenting.
Winner of the Philip L. Gildenberg S&F Resident Award, Mark R. Witcher, MD, presented his research, Memory Task-specific Encoding by Neuronal Networks in the Human Hippocampus.
Only half of women with cystic fibrosis (CF) report using contraception and frequently apt to become pregnant unintentionally, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results of the study were presented earlier this week at the 2015 American Congress of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting in San Francisco. As recently as the 1960s, children with cystic fibrosis – an inherited disease that causes thick, sticky mucus to form in the lungs, pancreas, and other organs – often died before attending elementary school. Today many people with the disease live into their 30s, 40s and beyond.
Preterm babies with retinopathy of prematurity (ROP) treated using bevacizumab, a growth inhibitor, have been found to have lower motor scores than babies treated with traditional laser ablation. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the William H. Sweet Young Investigators Award, Frank William Petraglia III, presented his research on the relationship between the efficacy of spinal cord stimulation (SCS) to block pains signals and the amount of time elapsed between diagnosis and implantation.
Winner of the Stryker Neuro-oncology Award, Darryl Lau, MD, presented results from A prospective phase II clinical trial of 5-aminolevulinic acid to correlate intraoperative fluorescence intensity with histologic cellularity.
Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have developed a new computer model to describe how cholesterol deposits, known as drusen, behave in the retina in the dry form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Scientists have found that baicalein significantly lowers eye pressure and may act as an all-natural treatment for glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the Young Neurosurgeons Abstract Award, Abdullah H. Feroze, B.S., presented his abstract, entitled Neural Placode Tissue Derived from Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells.
Winner of the Integra Foundation Award, Charles Lee, a student at the University of Rochester, studied the relationship between how many pituitary surgeries a neurosurgeon does and the overall cost of care for patients for patients in New York State.
Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the Sanford J. Larson, MD, PhD Award, Chetan Bettegowda, MD, will be presenting his abstract titled Somatic Mutations in SUZ12 in Malignant Peripheral Nerve Sheath Tumors.
L-DOPA, a routine drug taken by patients suffering from Parkinson’s disease, has been found to delay the onset of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Fund Awardee, Amanda Muhs Saratsis, MD, assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and an attending physician at Ann & Robert H. Lurie Hospital of Chicago, will examine the underpinnings of pediatric brainstem glioma. Saratsis hopes to identify potential therapeutic targets and biomarkers of this disease that will improve clinical diagnosis and management.
Researchers have identified a new target for stopping the progressive death of cells in the eye that leads to vision loss in glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have found that blocking the connections between cells in the retina can prevent toxins in one cell from spreading – and killing – its neighbors. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Col
Paving the way for drug discovery efforts, researchers have found a target that – when inhibited – reduces inflammation associated with vision loss in patients with diabetic retinopathy (DR). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
A new study found that eye drops were just as effective as eye injections for treating the wet form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Scientists have identified new biomarkers that could distinguish Sjögren’s Syndrome (SS) from other autoimmune diseases in days or weeks, improving on a current time to diagnosis of four-plus years. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo
A new study finds that when cells in the eye do not have enough oxygen, they improperly sort proteins, an issue that has been implicated in age-related macular degeneration (AMD) and Alzheimer’s disease. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Winner of the Brian D. Silber Award, Claudio Tatsui, MD, will present his abstract that shares his research, titled Laser Interstitial Thermotherapy as an Alternative to Separation Surgery in the Management of Spinal Metastasis.
Winner of the DePuy Synthes Spinal Cord Injury Resident Award, Nickalus R. Khan, MD, presented his research, A Meta-analysis of Spinal Surgical Site Infection and Vancomycin Powder.
Winner of the Stewart B. Dunsker, MD, Award, Khoi Duc Than, MD, presented his research, How to Predict Return to Work After Lumbar Discectomy: Answers from the NeuroPoint SD Registry.
Researchers found that 70% of patients received a dose of hydroxychloroquine that exceeded safety guidelines, and can potentially cause vision loss, in an inner city hospital. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Icahn School of Medicine at Mount Sinai researchers presented several landmark studies at the 2015 American Association for Thoracic Surgery (AATS) meeting in Seattle.
Winner of the Best International Abstract Award, Jeffrey V. Rosenfeld, MD, MS, presented his research, The Development of a Wireless Multielectrode Cortical Prosthesis for Restoration of Vision in Blind Individuals.
Matthew Joseph McGirt, MD, FAANS, presented his research, Patient Reported Outcomes 3-Months after Spine Surgery: Is it an Accurate Predictor of 12-Month?
Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV, according to results from the Longitudinal Study of the Ocular Complications of AIDS (LSOCA) presented today at the 2015 ARVO Annual Meeting in Denver, CO.
Scientists suggest exosomes released by the eye help speed up the drainage of fluid — offering another avenue to treat glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Risk of developing age-related macular degeneration higher in patients with AIDS Denver, Colo. – Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV, according to results from the Longitudinal Study of the Ocular Complications of AIDS (LSOCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have identified a genetic link between schizophrenia and strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
Researchers have determined that the three-dimensional organization of DNA in photoreceptor cells plays a crucial role in their function. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right